Serial 79201092
Live / Registered — Registered — international registration renewed (as of 26 Aug 2023)
What this means for you
Registered since 11 Jul 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §71 ten-year affidavit of use is due by 11 Jul 2027, and its filing window is open now).
Record
- Serial number
- 79201092
- Registration number
- 5238870
- Mark type
- Design / logo
- Filed
- 05 Sept 2016
- Published for opposition
- 25 Apr 2017
- Registered
- 11 Jul 2017
- Next maintenance filing
- §71 ten-year affidavit of use, due by 11 Jul 2027 (grace period to 11 Jan 2028)
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; [ pharmaceutical preparations for the prevention and treatment of cancer and tumors; ] pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Owner
- NOVARTIS AG, Basel, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prosecution history
- 11 Jul 2026 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 14 Sept 2023 — INTERNATIONAL REGISTRATION RENEWED
- 26 Aug 2023 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 26 Aug 2023 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 15 Aug 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 31 Jan 2023 — TEAS SECTION 71 & 15 RECEIVED
- 11 Jul 2022 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 03 Nov 2017 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 16 Oct 2017 — FINAL DISPOSITION NOTICE SENT TO IB
- 16 Oct 2017 — FINAL DISPOSITION PROCESSED
- 11 Oct 2017 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 11 Jul 2017 — REGISTERED-PRINCIPAL REGISTER
- 25 Apr 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Apr 2017 — PUBLISHED FOR OPPOSITION
- 05 Apr 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED